SF
CBAY

Synovus Financial’s Cymabay Therapeutics CBAY Stock Holding History

Synovus Financial’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-233
Closed -$1K – 1525
2020
Q2 		$1K Hold
233
– – ﹤0.01% 1539
2020
Q1 		$0 Hold
233
– – ﹤0.01% 2256
2019
Q4 		$0 Hold
233
– – ﹤0.01% 1606
2019
Q3 		$1K Hold
233
– – ﹤0.01% 1434
2019
Q2 		$2K Hold
233
– – ﹤0.01% 1331
2019
Q1 		$3K Hold
233
– – ﹤0.01% 1321
2018
Q4 		$2K Hold
233
– – ﹤0.01% 1337
2018
Q3 		$3K Buy
+233
New +$2.89K ﹤0.01% 1311

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return